In recent years, food allergies have emerged as a significant global health concern that affect an increasing percentage of the population. Despite being under investigation and discussed as a major or minor elicitor of food allergies, soybean remains a notable allergenic food source, affecting approximately 0.3%–3% of people worldwide, with a higher prevalence in Asian countries. Allergic reactions to soy can manifest as mild symptoms or progress to severe, life‐threatening conditions such as anaphylaxis. Consequently, there is an urgent need for the specific detection of soy allergens in food to mitigate the risk of inadvertent exposure and associated allergic reactions. State‐of‐the‐art methods for detecting food allergens include immunoassays utilizing either food source‐ or, ideally, allergen‐specific antibodies, along with mass spectrometry for detecting specific protein‐derived peptides. However, many commercially available immunoassays predominantly utilize polyclonal antibodies, which can confirm the presence of the entire food source but lack specificity for individual allergens. In response to this limitation, the aim is to develop specific monoclonal antibodies targeting individual soy allergens. These antibodies enable “component‐resolved analysis” of food samples, aligning with the emerging trend of component‐resolved diagnosis in allergy research. The generated monoclonal antibodies not only offer the ability to detect individual soy allergens in food and raw materials but also serve as valuable tools for quality and safety control of materials used in oral immunotherapy and allergy diagnosis. This improvement contributes significantly to aiding people with soy allergies and can be adapted for other food allergenic sources. This advancement represents a pivotal step toward enhancing the precision and comprehensiveness of allergen detection methodologies, addresses the specific challenges faced by individuals with soy allergies, and lays the foundation for broader applications to other food allergenic sources.
Wheat and soybeans are widely consumed foods and important sources of food allergens, affecting approximately 0.4-1% and 0.3-3% globally, respectively. Although symptoms are often mild, reliable allergen detection is essential to prevent exposure and ensure effective risk control. Immunoassays employing monoclonal antibodies (mAB) enable component resolved analysis by specifically targeting individual major food allergens such as amylase-trypsin inhibitors (ATIs) and β-conglycinin (Gly m 5). Two ATI-specific mABs and two Gly m 5 subunit-specific mABs (α and β) were generated in Balb/c mice and characterized using wheat and soy protein extracts, purified protein fractions, self-produced recombinant allergens, and potentially cross-reactive protein extracts by competitive ELISA and Western Blot. Despite functional differences between small enzyme inhibitors (ATIs) and large storage proteins (Gly m 5), mABs enabled specific detection of both allergen types, demonstrating the versatility of antibody-based immunoassays and supporting improved food safety, labeling, and allergen management for wheat- and soy-allergic individuals.
Wheat amylase–trypsin inhibitors (ATIs) are known for their allergenic properties, but their precise role in celiac disease and other wheat-related disorders remains unclear. Pure ATI preparations provide a basis for detailed biochemical and immunologic characterization; however, the complexity of isolating ATIs in the absence of other immunoreactive wheat proteins is an ongoing challenge. To address this limitation, bacterial and yeast heterologous expression systems were evaluated for the production of pure ATI preparations. While the synthesis of recombinant ATIs 0.28 and CM3 in Escherichia coli was challenging regarding protein solubility, promising results were observed for ATIs 0.19, CM1 and CM3 expressed in Pichia pastoris, both in terms of solubility and protein yields. The biochemical and immunoreactive properties of these recombinant ATIs were evaluated by SDS-PAGE, MALDI-TOF MS, LC-MS/MS, circular dichroism analysis, and in vitro inhibitory and immunoassays, and compared to native ATIs isolated from wheat. Our findings shed light on the difficulties in isolating pure ATIs and provide valuable insights into the potential impact of these proteins on human health. By using innovative expression systems, we aim to contribute to the detailed biochemical and immunogenic characterization of ATIs and improve the understanding of their role in wheat-related disorders and associated allergic responses.